Tumor-stroma interactions in tumorigenesis: Lessons from stem cell biology

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 5, 2012, Pages 1871-1887

  Briest, Franziska ^a   Berndt, Alexander ^a   Clement, Joachim ^b   Junker, Kerstin ^a   Von Eggeling, Ferdinand ^a   Grimm, Susanne ^a   Friedrich, Karlheinz ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Clinic for Internal Medicine II Südharzklinikum Nordhausen   (Germany)

Author keywords

Metastasis; Microenvironment; Review; Stem cell; Stem cell niche; Tumor associated fibroblast; Tumor stroma

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 21; INTERLEUKIN 6; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE; STAT1 PROTEIN; STAT3 PROTEIN; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN;

APOPTOSIS; BASEMENT MEMBRANE; BONE MARROW CELL; CANCER LOCALIZATION; CARCINOGENESIS; CELL COMMUNICATION; CELL HOMING; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; EMBRYO CELL; HELICOBACTER PYLORI; IMMUNE SYSTEM; METASTASIS; MICROENVIRONMENT; PHENOTYPE; PROTEIN FUNCTION; REVIEW; STEM CELL; STEM CELL NICHE; STROMA; SUPPRESSOR CELL; TROPHOBLAST; CELL MOTION; HUMAN; IMMUNOLOGY; NEOPLASM; PATHOLOGY; STROMA CELL; TUMOR ESCAPE;

CELL MOVEMENT; CELL PROLIFERATION; HUMANS; NEOPLASMS; STEM CELLS; STROMAL CELLS; TUMOR ESCAPE;

EID: 84860856777     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Review

References (183)

1. H. Li, X. Fan, J. Houghton: Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 101, 805-15 (2007) (Pubitemid 47040863)
2. TA. Mitsiadis, O. Barrandon, A. Rochat, Y. Barrandon, C. DE Bari: Stem cell niches in mammals. Exp Cell Res. 313, 3377-85 (2007) (Pubitemid 47404556)
3. P. Ehrlich: Ueber den jetzigen Stand der Karzinomforschung. Ned Tijdschr Geneeskd 5, 273-290 (1909)
4. R. Kim, M. Emi, K. Tanabe: Cancer immunoediting from immune surveillance to immune escape. Immunology 121, 1-14 (2007) (Pubitemid 46537674)
5. V. Shankaran, H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson, L. J. Old, R. D. Schreiber: IFNgamma and lymphocytes prevent primary tumor development and shape tumor immunogenicity. Nature 410, 1107-11 (2001) (Pubitemid 32391043)
6. Z. Qin, J. Schwartzkopff, F. Pradera, T. Kammertoens, B. Seliger, H. Pircher, T. Blankenstein: A critical requirement of IFNgamma mediated angiostasis for tumor rejection by CD8+ T cells. Cancer Res 63, 4095-100 (2003) (Pubitemid 36917932)
7. M. Spiotto, D. A. Rowley, H. Schreiber: Bystander elimination of antigen loss variants in established tumors. Nat Med 10, 294-8 (2004) (Pubitemid 38667621)
8. R. T. Prehn: The immune reaction as a stimulator of tumor growth. Science 176, 170-1 (1972)
9. T. L. Whiteside: The tumor microenvironment and its role in promoting tumor growth. Oncogene 27, 5904-12 (2008)
10. M. Karin, F. R. Greten: NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5, 749-59 (2005) (Pubitemid 41400849)
11. M. Karin: Nuclear factor-kappaB in cancer development and progression. Nature 441, 431-6 (2006) (Pubitemid 44050137)
12. A. Khoshnan, C. Tindell, I. Laux, D. Bae, B. Bennett, A. E. Nel: The NF-kappa B cascade is important in Bcl-xL expression and for the anti-apoptotic effects of the CD28 receptor in primary human CD4+ lymphocytes. J Immunol 165, 1743-54 (2000) (Pubitemid 30643123)
13. E. Varfolomeev, T. Goncharov, A. V. Fedorova, J. N. Dynek, K. Zobel, K. Deshayes, W. J. Fairbrother, D. Vucic: c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J Biol Chem 283, 24295-9 (2008)
14. D. J. Kessler, M. P. Duyao, D. B. Spicer, G. E. Sonenshein: NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts. J Exp Med 176, 787-92 (1992)
15. M. Hinz, D. Krappmann, A. Eichten, A. Heder, C. Scheidereit, M. Strauss: NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to- S-phase transition. Mol Cell Biol 19, 2690-8 (1999)
16. C. Tsatsanis, A. Androulidaki, M. Venihaki, A. N. Margioris: Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 38, 1654-61 (2006) (Pubitemid 43947653)
17. S. Wang, S. S. Leonard, V. Castranova, V. Vallyathan, X. Shi: The role of superoxide radical in TNF-alpha induced NF-kappaB activation. Ann Clin Lab Sci 29, 192-9 (1999) (Pubitemid 29336887)
18. S. P. Hussain, L. J. Hofseth, C. C. Harris: Radical causes of cancer. Nat Rev Cancer 3, 276-85 (2003) (Pubitemid 37328863)
19. M. Xiao, C.E. Inal, V.I. Parekh, X.H. Li, M.H. Whitnall: Role of NF-kappaB in hematopoietic niche function of osteoblasts after radiation injury. Exp Hematol. 37, 52-64 (2009)
20. D. Widera, I. Mikenberg, M. Elvers, C. Kaltschmidt, B. Kaltschmidt: Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK/NF-kappaB signaling. BMC Neurosci. 7, 64 (2006)
21. D. Widera, A. Kaus, C. Kaltschmidt, B. Kaltschmidt: Neural stem cells, inflammation and NF-kappaB: basic principle of maintenance and repair or origin of brain tumours?. J Cell Mol Med. 12, 459-70 (2008) (Pubitemid 351555127)
22. A. King, D.S. Allan, M. Bowen, S.J. Powis, S. Joseph, S. Verma, S.E. Hiby, A.J. McMichael, Y.W. Loke, V.M. Braud: HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur J Immunol. 30, 1623-31 (2000) (Pubitemid 30342804)
23. L. Ridolfi, M. Petrini, L. Fiammenghi, A. Riccobon, R. Ridolfi: Human embryo immune escape mechanisms rediscovered by the tumor. Immunobiology 241, 61-76 (2009)
24. R. Marin, F. Ruiz-Cabello, S. Pedrinaci, R. Mendez, P. Jimenez, D.E. Geraghty, F. Garrido: Analysis of HLA-E expression in human tumors. Immunogenetics 54, 767-75 (2003) (Pubitemid 36384471)
25. J. Bubenik: MHC class I down-regulation: tumour escape from immune surveillance? Int J Oncol. 25, 487-91 (2004)
26. I. Algerra, A. Garcia-Lora, T. Cabrera, F. Ruiz-Cabello, F. Garrido: The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape. Cancer Immunol Immunother 53, 904-10 (2004) (Pubitemid 39312657)
27. F.M. Marincola, E.M. Jaffee, D.J. Hicklin, S. Ferrone: Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 74, 181-273 (2000)
28. B. Seliger, F.M. Marincola, S. Ferrone, H. Abken: The complex role of B7 molecules in tumor immunology. Trends Mol Med. 14, 550-9 (2008)
29. V. Groh, J. Wu, C. Yee, T. Spies: Tumour-derived soluble MIC ligands impair expression of NKG2D and Tcell activation. Nature 419, 734-8 (2002) (Pubitemid 35177960)
30. A. Widschwendter, S. Tonko-Geymayer, T. Welte, G. Daxenbichler, C. Marth, W. Doppler: Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin Cancer Res 8, 3065-74 (2002) (Pubitemid 35155015)
31. D. A. Frank: STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett 251, 199-210 (2007) (Pubitemid 46680370)
32. H. Yu, M. Kortylewski, D. Pardoll: Crosstalk between cancer and immune cells: role of STAT3 in the tumor microenvironment. Nat Rev Immunol 7, 41-51 (2007) (Pubitemid 46020826)
33. A.P. Vicari, C. Caux, G. Trinchieri: Tumour escape from immune surveillance through dendritic cell inactivation. Semin Cancer Biol 12, 33-42 (2002) (Pubitemid 34087896)
34. D. Gabrilovich: Mechanisms and functional significance of tumor-induced dendritic-cell defects. Nat Rev Immunol 4, 941-52 (2004) (Pubitemid 39620069)
35. H. Sumimoto, F. Imabayashi, T. Iwata, Y. Kawakami: The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells. J Exp Med 203, 1651-6 (2006)
36. T.R. Mosmann, R.L. Coffman: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 7, 145-73 (1989) (Pubitemid 19138011)
37. M. Kujawski, M. Kortylewski, H. Lee, A. Herrmann, H. Kay, H. Yu: Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J Clin Invest 118, 3367-77 (2008)
38. Y. Fan, J. Ye, F. Shen, Y. Zhu, Y. Yeghiazarians, W. Zhu, Y. Chen, M.T. Lawton, W. L. Young, G. Y. Yang: Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab 28, 90-8 (2008)
39. T. Kaiga, M. Sato, H. Kaneda, Y. Iwakura, T. Takayama, H. Tahara: Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12. J Immunol 178, 7571-80 (2007) (Pubitemid 46898026)
40. M. Numasaki, M. Watanabe, T. Suzuki, H. Takahashi, A. Nakamura, F. McAllister, T. Hishinuma, J. Goto, M. T. Lotze, J. K. Kolls, H. Sasaki: IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2- dependent angiogenesis. J Immunol 175, 6177-89 (2005) (Pubitemid 41508106)
41. J. L. Langowski, X. Zhang, L. Wu, J. D. Mattson, T. Chen, K. Smith, B. Basham, T. McClanahan, R. A. Kastelein, M. Oft: IL-23 promotes tumor incidence and growth. Nature 442, 461-5 (2006) (Pubitemid 44264796)
42. M. Kortylewski, H. Yu: Role of Stat3 in suppressing anti-tumor immunity. Curr Opin Immunol 20, 228-33 (2008)
43. R. Bedel, A. Thiery-Vuillemin, C. Grandclement, J. Balland, J.P. Remy-Martin, B. Kantelip, J.R. Pallandre, X. Pivot, C. Ferrand, P. Tiberghien, C. Borg: Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells. Cancer Res. 71, 1615-1626 (2011)
44. A. Wu, J. Wei, L.Y. Kong, Y. Wang, W. Priebe, W. Qiao, R. Sawaya, A.B. Heimberger: Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol 12, 1113-25 (2010)
45. S. Beyth, Z. Borovsky, D. Mevorach, M. Liebergall, Z. Gazit, H. Aslan, E. Galun, J. Rachmilewitz: Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105, 2214-9 (2005)
46. F. Cheng, H.W. Wang, A. Cuenca, M. Huang, T. Ghansah, J. Brayer, W.G. Kerr, K. Takeda, S. Akira, S.P. Schoenberger, H. Yu, R. Jove, E.M. Sotomayor: A critical role for Stat3 signaling in immune tolerance. Immunity 19, 425-36 (2003) (Pubitemid 37153418)
47. D. Gur-Wahnon, Z. Borovsky, S. Beyth, M. Liebergall, J. Rachmilewitz: Contact-dependent induction of regulatory antigen-presenting cells by human mesenchymal stem cells is mediated via STAT3 signaling. Exp Hematol 35, 426-33 (2007)
48. J. Yang, A.L. van Oosten, T.W. Theunissen, G. Guo, J.C. Silva, A. Smith: Stat3 activation is limiting for reprogramming to ground state pluripotency. Cell Stem Cell 7, 319-28 (2010)
49. C. Charalambous, T.C. Chen, F.M. Hofman: Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme. Neurosurg Focus 20, E22 (2006)
50. K.G. Neiva, Z. Zhang, M. Miyazawa, K. A. Warner, E. Karl, J.E. Noer: Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia 11, 583-93 (2009)
51. A. Mantovani, T. Schioppa, C. Porta, P. Allavena, A. Sica: Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25, 315-22 (2006) (Pubitemid 44922352)
52. Z.G. Fridlender, J. Sun, S. Kim, V. Kapoor, G. Cheng, L. Ling, G.S. Worthen, S.M. Albelda: Polarization of Tumor-Associated Neutrophil. Cancer Cell 16, 183-94 (2009)
53. A. Clayton, R. A. Evans, E. Pettit, M. Hallett, J. D. Williams, R. Steadman: Cellular activation through the ligation of intercellular adhesion molecule-1. J Cell Sci 111, 443-53 (1998) (Pubitemid 28098394)
54. M. Zeisberg, F. Strutz, G. A. Mueller: Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol 3, 111-20 (2000)
55. S. Murakami, H. Okada: Lymphocyte-fibroblast interactions. Crit Rev Oral Biol Med 8, 40-50 (1997) (Pubitemid 27132231)
56. C. C. Hughes: Endothelial-stromal interactions in angiogenesis. Curr Opin Hematol 15, 204-9 (2008) (Pubitemid 351507572)
57. M. Spector: Musculoskeletal connective tissue cells with muscle: expression of muscle actin in and contraction of fibroblasts, chondrocytes, and osteoblasts. Wound Repair Regen 9, 11-8 (2001) (Pubitemid 32268509)
58. R. Schleip, W. Klingler, F. Lehmann-Horn: Active fascial contractility: Fascia may be able to contract in a smooth muscle-like manner and thereby influence musculoskeletal dynamics. Med Hypotheses 65, 273-7 (2005) (Pubitemid 40744753)
59. A. Desmouliere, A. Geinoz, F. Gabbiani, G. Gabbiani: Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122, 103-11 (1993) (Pubitemid 23188802)
60. M. B. Vaughan, E. W. Howard, J. J. Tomasek: Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 257, 180-9 (2000) (Pubitemid 30324656)
61. L. Mueller, F. A. Goumas, M. Affeldt, S. Sandtner, U. M. Gehling, S. Brilloff, J. Walter, N. Karnatz, K. Lamszus, X. Rogiers, D. C. Broering: Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. Am J Pathol 171, 1608-18 (2007) (Pubitemid 350158321)
62. C. S. Wang, B. Tetu: Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction. Int J Cancer 99, 792-9 (2002) (Pubitemid 34575695)
63. Y. A. DeClerck: Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. Eur J Cancer 36, 1258-68 (2000)
64. R. Hildenbrand, A. Schaaf: The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Int J Oncol 34, 15-23 (2009)
65. A. M. Sieuwerts, J. G. Klijn, S. C. Henzen-Logmans, J. A. Foekens: Cytokine-regulated urokinase-typeplasminogen- activator (uPA) production by human breast fibroblasts in vitro. Breast Cancer Res Treat 55, 9-20 (1999) (Pubitemid 29353970)
66. H. Kosmehl, A. Berndt, D. Katenkamp: Molecular variants of fibronectin and Laminin. Structure, physiological occurrence and pathohistological aspects. Virch Arch 429, 311-322 (1996) (Pubitemid 26421391)
67. D. W. Powell, R. C. Mifflin, J. D. Valentich, S. E. Crowe, J. I. Saada, A. B. West: Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol 277, 183-201 (1999)
68. J. T. Norman, I. M. Clark, P. L. Garcia: Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 58, 2351-66 (2000)
69. H. Pilch, K. Schlenger, E. Steiner, P Brockerhoff, P. Knapstein, P. Vaupel: Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts. Int J Gynecol Cancer 11, 137-42 (2001) (Pubitemid 32381662)
70. G. M. Saed, W. Zhang, M. P. Diamond: Molecular characterization of fibroblasts isolated from human peritoneum and adhesions. Fertil Steril 75, 763-8 (2001) (Pubitemid 32273513)
71. K. Noma, K. S. Smalley, M. Lioni, Y. Naomoto, N. Tanaka, W. El-Deiry, A. J. King, H. Nakagawa, M. Herlyn: The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis. Gastroenterology 134, 1981-93 (2008) (Pubitemid 351790740)
72. L. A. Kunz-Schughart, R. Knuechel: Tumor-associated fibroblasts (part II): Functional impact on tumor tissue. Histol Histopathol 17, 623-37 (2002) (Pubitemid 34411215)
73. A. Orimo, P. B. Gupta, D. C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V. J. Carey, A. L. Richardson, R. A. Weinberg: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-48 (2005) (Pubitemid 40692295)
74. T. Kijima, G. Maulik, P. C. Ma, E. V. Tibaldi, R. E. Turner, B. Rollins, M. Sattler, B. E. Johnson, R. Salgia: Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res 62, 6304-11 (2002) (Pubitemid 35244485)
75. F. Marchesi, P. Monti, B. E. Leone, A. Zerbi, A. Vecchi, L. Piemonti, A. Mantovani, P. Allavena: Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 64, 8420-7 (2004)
76. F. Vianello, P. Kraft, Y. T. Mok, W. K. Hart, N. White, M. C. Poznansky: A CXCR4-dependent chemorepellent signal contributes to the emigration of mature singlepositive CD4 cells from the fetal thymus. J Immunol 175, 5115-25 (2005) (Pubitemid 41456395)
77. M. J. Ellis, C. Singer, A. Hornby, A. Rasmussen, K. J. Cullen: Insulin-like growth factor mediated stromalepithelial interactions in human breast cancer. Breast Cancer Res Treat 31, 249-61 (1994) (Pubitemid 24323466)
78. M. Ao, O. E. Franco, D. Park, D. Raman, K. Williams, S. W. Hayward: Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res 67, 4244-53 (2007) (Pubitemid 46815071)
79. F. Ponten, Z. Ren, M. Nister, B. Westermark, J. Ponten: Epithelial-stromal interactions in basal cell cancer: the PDGF system. J Invest Dermatol 102, 304-9 (1994) (Pubitemid 24095495)
80. T. Nakamura, K. Matsumoto, A. Kiritoshi, Y. Tano, T. Nakamura: Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res 57, 3305-13 (1997) (Pubitemid 27351751)
81. S. Ishii, Y. Okada, T. Kadoya, Y. Matsuzaki, T. Shimazaki, H. Okano: Stromal Cell-Secreted Factors Promote the Survival of Embryonic Stem Cell-Derived Early Neural Stem/Progenitor Cells Via the Activation of MAPK and PI3K-Akt Pathways. J Neurosci Res 88, 722-34 (2010)
82. D.T. Scadden: The stem-cell niche as an entity of action. Nature 441, 1075-9 (2006)
83. P. Ducy, T. Schinke, G. Karsenty: The Osteoblast: A Sophisticated Fibroblast under Central surveillance. Science 289, 1501-4 (2000)
84. K. Miyazawa, D.A. Williams, A. Gotoh, J. Nishimaki, H.E. Broxmeyer, K. Toyama: Membranebound steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit geneencoded protein than its soluble form. Blood 85, 641-9 (1995)
85. D. Kent, M. Copley, C. Benz, B. Dykstra, M. Bowie, C. Eaves: Regulation of Hematopoietic Stem Cells by the Steel Factor/KIT Signaling Pathway. Clin Cancer Res 14, 1926-30 (2010) (Pubitemid 351551100)
86. A.P. de Barros, C.M. Takiya, L.R. Garzoni, M.L. Leal-Ferreira, H.S. Dutra, L.B. Chiarini, M.N. Meirelles, R. Borojevic, M.I. Rossi: Osteoblasts and bone marrow mesenchymal stromal cells control hematopoietic stem cell migration and proliferation in 3D in vitro model. PLoS One 5, e9093 (2010)
87. O. Kollet, A. Dar, S. Shivtiel, A. Kalinkovich, K. Lapid, Y. Sztainberg, M. Tesio, R.M. Samstein, P. Goichberg, A. Spiegel, A. Elson, T. Lapidot: Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 12, 657-64 (2006) (Pubitemid 43865234)
88. M.J. Kiel, S.J. Morrison: Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 8, 290-301 (2008) (Pubitemid 351432804)
89. D. Zipori: The renewal and differentiation of hemopoietic stem cells. FASEB J 6, 2691-7 (1992)
90. P. Gupta, B.R. Blazar, K. Gupta, C.M. Verfaillie: Human CD34(+) bone marrow cells regulate stromal production of interleukin-6 and granulocyte colony-stimulating factor and increase the colony-stimulating activity of stroma. Blood 91, 3724-33 (1998) (Pubitemid 28225740)
91. T. Lapidot, I. Petit: Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 30, 973-81 (2002) (Pubitemid 35286613)
92. A. Dar, O. Kollet, T. Lapidot: Mutual, reciprocal SDF- 1/CXCR-4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 34, 967-75 (2006) (Pubitemid 44080383)
93. H. Kobayashi, J.M. Butler, R. O'Donnell, M. Kobayashi, B.S. Ding, B. Bonner, V.K. Chiu, D.J. Nolan, K. Shido, L. Benjamin, S. Rafii: Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol 12, 1046-56 (2010)
94. K. Chen, H. Bai, M. Arzigian, Y.X Gao, J. Bao, W.S. Wu, W.F. Shen, L. Wu, Z.Z. Wang: Endothelial cells regulate cardiomyocyte development from embryonic stem cells. J Cell Biochem 111, 29-39 (2010)
95. X.D. Chen: Extracellular Matrix Provides an Optimal Niche for the Maintenance and Propagation of Mesenchymal Stem Cells. Birth Defects Res C Embryo Today 90, 45-54 (2010)
96. W.P. Daley, S.B. Peters, M. Larsen: Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci 121, 255-64 (2008) (Pubitemid 351356696)
97. R. M. Bremnes, R. Veve, F. R. Hirsch, W. A. Franklin: The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 36, 115-24 (2002) (Pubitemid 34302891)
98. G. Berx, K. F. Becker, H. Hoefler, F. van Roy: Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 12, 226-37 (1998) (Pubitemid 28418891)
99. R. E. Bachelder, S. O. Yoon, C. Franci, A. G. de Herreros, A. M. Mercurio: Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 168, 29-33 (2005) (Pubitemid 40111054)
100. H. Peinado, M. Del Carmen Iglesias-de la Cruz, D. Olmeda, K. Csiszar, K. S. Fong, S. Vega, M. A. Nieto, A. Cano, F. Portillo: A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J 24, 3446-58 (2005) (Pubitemid 41486782)
101. C. Sahlgren, M. V. Gustafsson, S. Jin, L. Poellinger, U. Lendahl: Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A 105, 6392-7 (2008)
102. A. C. Chiang, J. Massague: Molecular basis of metastasis. N Engl J Med 359, 2814-23 (2008)
103. Y. Fujita, G. Krause, M. Scheffner, D. Zechner, H. E. Leddy, J. Behrens, T. Sommer T, W. Birchmeier: Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 4, 222-31 (2002) (Pubitemid 34218196)
104. G. Christofori: New signals from the invasive front. Nature 441, 444-50 (2006) (Pubitemid 44050139)
105. E. J. Williams, G. Williams, F. V. Howell, S. D. Skaper, F. S. Walsh, P. Doherty: Identification of an Ncadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth. J Biol Chem 276, 43879-86 (2001)
106. Y. Xu, G. Carpenter: Identification of cadherin tyrosine residues that are phosphorylated and mediate Shc association. J Cell Biochem 75, 264-71 (1999) (Pubitemid 29463495)
107. L.D. Derycke, M. E. Bracke: N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Dev Biol 48, 463-76 (2004) (Pubitemid 39360397)
108. K. Pardali, A. Moustakas: Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 1775, 21-62 (2007) (Pubitemid 44881193)
109. B. Ozdamar, R. Bose, M. Barrios-Rodiles, H. R. Wang, Y. Zhang, J. L. Wrana: Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307, 1603-9 (2005)
110. I. Stamenkovic: Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10, 415-33 (2000) (Pubitemid 32181912)
111. K. Nabeshima, H. Iwasaki, K. Koga, H. Hojo, J. Suzumiya, M. Kikuchi: Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 56, 359-67 (2006) (Pubitemid 43886799)
112. W. Hornebeck, H. Emonard, J. C. Monboisse, G. Bellon: Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol 12, 231-41 (2002) (Pubitemid 34833066)
113. W. H. Yu, Jr J. F. Woessner, J. D. McNeish, I Stamenkovic: CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 16, 307-23 (2002) (Pubitemid 34111411)
114. P. A. Andreasen, L. Kjøller, L. Christensen, M. J. Duffy: The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72, 1-22 (1997) (Pubitemid 27314632)
115. A. R. Kornblihtt, K. Vibe-Pedersen, F. E. Baralle: Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res 12, 5853-5868 (1984)
116. H. Matsuura, S. Hakomori: The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci U S A 82, 6517-6521 (1985) (Pubitemid 16230545)
117. C. French-Constant, W. L. Van de, H. F. Dvorak, R. O. Hynes: Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 109, 903-914 (1989) (Pubitemid 19197047)
118. F. Oyama, S. Hirohashi, Y. Shimosato, K. Titani, K. Sekiguchi: Oncodevelopmental regulation of the alternative splicing of fibronectin pre-messenger RNA in human lung tissues. Cancer Res 50, 1075-1078 (1990) (Pubitemid 20083989)
119. R. Chiquet-Ehrismann: Tenascins. Int J Biochem Cell Biol 36, 986-90 (2004) (Pubitemid 38501550)
120. G. Serini, M. L. Bochaton-Piallat, P. Ropraz, A. Geinoz, L. Borsi, L. Zardi, G. Gabbiani: The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 142, 873-81 (1998) (Pubitemid 28381502)
121. G. Orend, R. Chiquet-Ehrismann: Tenascin-C induced signalling in cancer. Cancer Letters 244, 143-163 (2006)
122. A. von Holst: Tenascin C in stem cell niches: redundant, permissive or instructive? Cells Tissues Organs 188, 170-177 (2008) (Pubitemid 351962240)
123. M. Aumailley, L. Bruckner-Tuderman, W. G. Carter, R. Deutzmann, E. Edgar, P. Ekblom, J. Engel, E. Engvall, E. Hohenester, J. C. Jones, H. K. Kleinman, M. P. Marinkovich, G. R. Martin, U. Mayer, G. Meneguzzi, J. H. Miner, K. Miyazaki, M. Patarroyo, M. Paulsson, V. Quaranta, J. R. Sanes, T. Sasaki, K. Sekiguchi, L. M. Sorokin, J. F. Talts, K. Tryggvason, J. Uitto, I. Virtanen, K. von der Mark, U. M. Wewer, Y. Yamada, P. D. Yurchenco: A simplified laminin nomenclature. Matrix Biol 24, 326-32 (2005) (Pubitemid 41021635)
124. M. Franz, T. Hansen, L. Borsi, C. Geier, P. Hyckel, P. Schleier, P. Richter, A. Altendorf-Hofmann, H. Kosmehl, A. Berndt: A quantitative colocalization analysis of large unspliced Tenascin-CL and Laminin-5/gamma2- chain in basement membranes of oral squamous cell carcinoma by confocal laser scanning microscopy. J Oral Pathol Med 36, 6-11 (2007) (Pubitemid 44973981)
125. M. P. Marinkovich: Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nat Rev Cancer 7, 370-80 (2007) (Pubitemid 46652480)
126. A. Berndt, L. Borsi, P. Hyckel, H. Kosmehl: Fibrillar co-deposition of laminin-5 and large unspliced tenascin-C in invasive front of oral squamous cell carcinoma in vivo and in vitro. Cancer Res Clinical Oncol 127, 286-292 (2001)
127. M. Franz, T. Hansen, P. Richter, L. Borsi, F. D. Boehmer, P. Hyckel, P. Schleier, D. Katenkamp, L. Zardi, H. Kosmehl, A. Berndt: Complex formation of the laminin-5 gamma2 chain and large unspliced tenascin in oral squamous cell carcinoma in vitro and in situ: implications for sequential modulation of extracellular matrix in the invasive front. Histochem Cell Biol 126, 125-131 (2006) (Pubitemid 43882546)
128. M. Larsen, V. V. Artym, J. A. Green, K. M. Yamada: The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol 18, 463-471 (2006) (Pubitemid 44332914)
129. S. Massberg, P. Schaerli, I. Knezevic-Maramica, M. Koellnberger, N. Tubo, E.A. Moseman, I.V. Huff, T. Junt, A.J. Wagers, I.B. Mazo, U.H. von Andrian: Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 131, 994-1008 (2007) (Pubitemid 350138089)
130. M.H. Cottler-Fix, T. Lapidot, I. Petit, O. Kollet, J.F. DiPersio, D. Link, S. Devine: Stem Cell Mobilization. Hematology Am Soc Hematol Educ Program 419-37 (2003)
131. Y. Vagima, A. Avigdor, P. Goichberg, S. Shivtiel, M. Tesio, A. Kalinkovich, K. Golan, A. Dar, O. Kollet, I Petit, O Perl, E. Rosenthal, I. Resnick, I. Hardan, Y.N. Gellman, D. Noar, A. Nagler, T. Lapidot: MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. J Clin Invest 119, 492-503 (2009)
132. R. Moehle, S. Rafii, M.A. Moore: The Role of Endothelium in the Regulation of Hematopoietic Stem Cell Migration. Stem Cells 16, 159-65 (1998)
133. C. Wittekind: Principles of lymphogenic and hematogenous metastasis and metastasis classification. Zentralbl Chir 121, 435-41 (1996) (Pubitemid 26235330)
134. G. P. Gupta, J. Massague: Cancer metastasis: building a framework. Cell 127, 679-95 (2006) (Pubitemid 44781029)
135. J. T. Price, T. Tiganis, A. Agarwal, D. Djakiew, E. W. Thompson: Epidermal growth factor promotes MDA-MB- 231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase Cdependent mechanism. Cancer Res 1999 59, 5475-8 (1999)
136. J. Wyckoff, W. Wang, E. Y. Lin, Y. Wang, F. Pixley, E. R. Stanley, T. Graf, J. W. Pollard, J. Segall, J. Condeelis: A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64, 7022-9 (2004)
137. C. LeBedis, K. Chen, L. Fallavollita, T. Boutros, P. Brodt: Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF. Int J Cancer 100, 2-8 (2002) (Pubitemid 34602057)
138. M. A. Moore: The role of chemoattraction in cancer metastases. Bioessays 23, 674-6 (2001) (Pubitemid 32792510)
139. C. Weidt, B. Niggemann, B. Kasenda, T. L. Drell, K. S. Zaenker, T. Dittmar: Stem cell migration: a quintessential stepping stone to successful therapy. Curr Stem Cell Res Ther 2, 89-103 (2007) (Pubitemid 46723148)
140. M. Kucia, K. Jankowski, R. Reca, M. Wysoczynski, L. Bandura, D.J. Allendorf, J. Zhang, J. Ratajczak, M.Z. Ratajczak: CXCR-4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35, 233-45
141. Y. R. Zou, A.H. Kottmann, M. Kuoda, I. Taniuchi, D.R. Littman: Function of the chemokine receptor CXCR-4 in haematopoiesis and in cerebellar development. Nature 393, 595-9 (1998) (Pubitemid 28319251)
142. R.K. Stumm, J. Rummel, V. Junker, C. Culmsee, M. Pfeiffer, J. Krieglstein, V. Hoellt, S. Schulz: A dual role for SDF-1/CXCR-4 chemokine receptor system in adult brain: Isoform-selective regulation of SDF-1 expression modulates CXCR-4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 22, 5865-78 (2002) (Pubitemid 35387631)
143. M.Z. Ratajczak, M. Majka, M. Kucia, J. Drukala, Z. Pietrzkowski, S. Peiper, A. Janowska-Wieczorek: Expression of functional CXCR-4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrowand hematopoietic stem/progenitor cells in muscles. Stem Cells 21, 363-71 (2003) (Pubitemid 36623177)
144. T. Maekawa, T. Ishii: Chemokine/receptor dynamics in the regulation of hematopoiesis. Intern Med 39, 90-100 (2000)
145. R. Horuk: Chemokine receptors. Cytokine Growth Factor Rev 12, 313-35 (2001) (Pubitemid 32851745)
146. Q. Ma, D. Jones, P.R. Borghesani, R.A. Segal, T. Nagasawa, T. Kishimoto, R.T. Bronson, T.A. Springer: Impaired B-lymphopoiesis, myelopoiesis and derailed cerebellar neuron migration in CXCR-4-and SDF-1- deficient mice. Proc Natl Acad Sci U S A 95, 9448-53 (1998) (Pubitemid 28506251)
147. T. Ara, Y. Nakamura, T. Egawa, T. Sugiyama, K. Abe, T. Kishimoto, Y. Matsui, T. Nagasawa: Impaired colonization of the gonads by primordial germ cells in mice lacking a chemokine stromal cell-derived factor-1 (SDF-1). Proc Natl Acad Sci U S A 100, 5319-23 (2003) (Pubitemid 36542703)
148. A. Pituch-Noworolska, M. Majka, A. Janowska-Wieczorek, M. Baj-Krzyworzeka, B. Urbanowicz, E. Malec, M.Z. Ratajczak: Circulating CXCR-4-positive stem/progenitor cells compete for SDF-1 positive niches in bone marrow, muscle and neural tissues: An alternative hypothesis to stem cell plasticity. Folia Histochem Cytobiol 41, 13-21 (2003) (Pubitemid 36215829)
149. F. Lazarini, T.N. Tham, P. Casanova, F. Arenzana-Seisdedos, M. Dubois-Dalcq: Role of the alpha-chemokine stromal cellderived factor (SDF-1) in the developing and mature central nervous system. Glia 42, 139-48 (2003) (Pubitemid 36565118)
150. H.M. Hatch, D. Zheng, M.L. Jorgensen, B.E. Petersen: A mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells 4, 339-51 (2002) (Pubitemid 36105802)
151. I.J. Crane, C.A. Wallace, S. McKillop-Smith, J.V. Forrester: CXCR-4 receptor expression on human retinal pigment epithelial cells from blood-retina barrier leads to chemokine secretion and migration in response to stromal cell-derived factor 1alpha. J Immunol 165, 4372-8 (2000)
152. R.K. Ganju, S.A. Brubaker, J. Meyer, P. Dutt, Y. Yang, S. Qin, W. Newman, J.E. Groopman: The alphachemokine stromal cell-derived factor-alpha binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 273, 23169-75 (1998)
153. R.D. Chernock, R.P. Cherla, R.K. Ganju: SHP2 and cbl participate in alpha-chemokine receptor CXCR-4- mediated signaling pathways. Blood 97, 608-15 (2001) (Pubitemid 32113391)
154. G. Helbig, K.W. Christopherson II, P. Bhat-Nakshatri, S. Kumar, H. Kishimoto, K.D. Miller, H.E. Broxmeyer, H. Nakshatri: NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR-4. J Biol Chem 278, 21631-8 (2003) (Pubitemid 36792563)
155. A. Peled, O. Kollet, T. Ponomaryov, I. Petit, S. Franitza, V. Grabovsky, M.M. Slav, A. Nagler, O. Lider, R. Alon, D. Zipori, T. Lapidot: The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34+ cells: Role in transendothelial/stromal migration and engraftment of NODSCID mice. Blood 95, 3289-96 (2000) (Pubitemid 30428455)
156. J. A. Burger, T. J. Kipps: CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107, 1761-7 (2006)
157. M. Wysoczynski, R. Reca, J. Ratajczak, M. Kucia, N. Shirvaikar, M. Honczarenko, Mills, J. Wanzeck, A. Janowska-Wieczorek, M. Z. Ratajczak: Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood 105, 40-8 (2005) (Pubitemid 40053061)
158. M. Kucia, R. Reca, K. Miekus, J. Wanzeck, W. Wojakowski, A. Janowska-Wieczorek, J. Ratajczak, M. Z. Ratajczak: Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23, 879-94 (2005) (Pubitemid 41170944)
159. A. Mueller, B. Homey, H. Soto, N. Ge, D. Catron, M. E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S. N. Wagner, J. L. Barrera, A. Mohar, E. Verastegui, A. Zlotnik: Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-6 (2001) (Pubitemid 32225831)
160. R. S. Taichman, C. Cooper, E. T. Keller, K. J. Pienta, N. S. Taichman, L. K. McCauley: Use of the stromal cellderived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62, 1832-7 (2002)
161. J. Wang, R. Loberg, R. S. Taichman: The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis. Cancer Metastasis Rev 25, 573-87 (2006) (Pubitemid 46071864)
162. B. R. Zetter: Adhesion molecules in tumor metastasis. Semin Cancer Biol 4, 219-29 (1993)
163. T. Dittmar, C. Heyder, E. Gloria-Maercker, W. Hatzmann, K. S. Zaenker: Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner. Clin Exp Metastasis 25, 11-32 (2008) (Pubitemid 351191223)
164. M. Burger, A. Glodek, T. Hartmann, A. Schmitt-Graeff, L.E. Silberstein, N. Fujii, T.J. Kipps, J.A. Burger: Functional expression of CXCR-4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 22, 8093-101 (2003) (Pubitemid 37487300)
165. S. Paget: The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 8, 98-101 (1989)
166. M. Marcellini, N. De Luca, T. Riccioni, A. Ciucci, A. Orecchia, P. M. Lacal, F. Ruffini, M. Pesce, F. Cianfarani, G. Zambruno, A. Orlandi, C. M. Failla: Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor. Am J Pathol 169, 643-54 (2006) (Pubitemid 44156320)
167. S. Hiratsuka, K. Nakamura, S. Iwai, M. Murakami, T. Itoh, H. Kijima, J. M. Shipley, R. M. Senior, M. Shibuya: MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2, 289-300 (2002) (Pubitemid 41043963)
168. S. Hiratsuka, A. Watanabe, H. Aburatani, Y. Maru: Tumor-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8, 1369-75 (2006) (Pubitemid 44835111)
169. R. N. Kaplan, R. D. Riba, S. Zacharoulis, A. H. Bramley, L. Vincent, C. Costa, D. D. MacDonald, D. K. Jin, K. Shido, S. A. Kerns, Z. Zhu, D. Hicklin, Y. Wu, J. L. Port, N. Altorki, E. R. Port, D. Ruggero, S. V. Shmelkov, K. K. Jensen, S. Rafii, D. Lyden: VEGFR1-positive haematopoietic bone marrow progenitors initiate the premetastatic niche. Nature 438, 820-7 (2005) (Pubitemid 41753060)
170. J. B. Sneddon, Z. Werb: Location, location, location: the cancer stem cell niche. Cell Stem Cell 1, 607-11 (2007) (Pubitemid 350215340)
171. A. K. Croker, A. L. Allan: Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cell Mol Med 12, 374-90 (2008) (Pubitemid 351555122)
172. P. N. Kelly, A. Dakic, J. M. Adams, S. L. Nutt, A. Strasser: Tumor growth need not be driven by rare cancer stem cells. Science 317, 337 (2007) (Pubitemid 47106366)
173. E. Quintana, M. Shackleton, M. S. Sabel, D. R. Fullen, T. M. Johnson, S. J. Morrison: Efficient tumor formation by single human melanoma cells. Nature 456, 593-8 (2008)
174. K. Rowan: Are cancer stem cells real? After four decades, debate still simmers. J Natl Cancer Inst 101, 546-7 (2009)
175. E. Perissinotto, G. Cavalloni, F. Leone, V. Fonsato, S. Mitola, G. Grignani, N. Surrenti, D. Sangiolo, F. Bussolino, W. Piacibello, M. Aglietta: Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression. Clin Cancer Res 11, 490-7 (2005) (Pubitemid 40116871)
176. N. Redjal, J.A. Chan, R.A. Segal, A.L. Kung: CXCR- 4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin Cancer Res 12, 6765-71 (2006) (Pubitemid 44876846)
177. Z. Zeng, I.J. Samudio, M. Munsell, J. An, Z. Huang, E. Estey, M. Andreeff, M. Konopleva: Inhibition of CXCR- 4 with the novel RCP168 peptide overcomes stromamediated chemoresistance in chronic and acute leukemias. Mol Cancer Ther 5, 3113-21 (2006) (Pubitemid 46092053)
178. J.K. Li, L. Yu, Y. Shen, L.S. Zhou, Y.C. Wang, J. H. Zhang: Inhibition of CXCR-4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. World J Gastroenterol 14, 2308-13 (2008) (Pubitemid 351877599)
179. A.K. Azab, J.M. Runnels, C. Pitsillides, A.S. Moreau, F. Azab, X. Leleu, X. Jia, R. Wright, B. Ospina, A.L. Carlson, C. Alt, N. Burwick, A.M. Roccaro, H.T. Ngo, M. Farag, M.R. Melhem, A. Sacco, N.C. Munshi, T. Hideshima, B.J. Rollins, K.C. Anderson, A.L. Kung, C.P. Lin, I.M. Ghobrial: CXCR-4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood 113, 4341-51 (2009)
180. Z. Zeng, Y.X. Shi, I.J. Samudio, R.Y. Wang, X. Ling, O. Frolova, M. Levis, J.B. Rubin, R.R. Negrin, E.H. Estey, S. Konoplev, M. Andreeff, M. Konopleva: Targeting the leukemia microenvironment by CXCR-4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. Blood 113, 6215-24 (2009)
181. Y.L. Tang, W. Zhu, M. Cheng, L. Chen, J. Zhang, T. Sun, R. Kishore, M.I. Phillips, D.W. Losordo, G. Qin: Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR-4 expression. Circ Res 104, 1209-16 (2009)
182. A. Blum, R.W. Childs, A. Smith, S. Patibandla, G. Zalos, L. Samsel, J.P. McCoy, G. Casandra, G. Csako, R.O. Cannon III: Targeted antagonism of CXCR-4 mobilizes progenitor cells under investigation for cardiovascular disease. Cytotherapy 11, 1016-9 (2009)
183. I. Pusic, J.F. DiPersio: Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR-4 inhibitor, in mobilization of hematopoietic stem and progenitor cells. Curr Opin Hematol 17, 319-26 (2010)